# SBSW earnings call intelligence

LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/SBSW) · [Earnings tab](https://www.lopjlb.com/stock/SBSW?tab=earnings)

Updated: 2026-09-01T06:01:28

Quarters analyzed: 8

## Cross-quarter narrative

Across six years of Sibanye‑Stillwater earnings calls the company moved from a vague outlook in 2021 to a more disciplined, balance‑sheet‑focused narrative by 2025. Early calls highlighted safety gains and modest cost inflation while wrestling with floods, illegal mining and labour unrest. By 2022‑Q4 the firm emphasized a strong cash position, a 6% dividend yield and the upside of lithium and PGM supply constraints, yet warned of load‑shedding risk. In 2023‑Q2 the tone shifted to mixed results, with gold recovery offsetting weaker PGM margins, continued cost‑control emphasis, renewable‑energy milestones and emerging skill‑shortage and legal‑challenge concerns. The 2024‑Q2 update underscored a ZAR 25 bn balance‑sheet boost, financing diversification, progress on Keliber and US PGM restructuring, while acknowledging commodity volatility, low palladium prices and seismicity. By H1‑2025 EBITDA surged, US restructuring began delivering cost reductions and the Kloof gold operation showed weakness. Throughout, recurring themes of operational risk, commodity price pressure and cost management persisted, while safety, balance‑sheet strength and renewable‑energy initiatives showed clear improvement.

## Latest CallCard · Q4

**Guidance:** vague

**Tone:** mgmt 0 · Q&A pressure 0 · divergence 0

## Quarter one-liners

- **2025 Q4:** —
- **2025 Q2:** H1 2025: EBITDA +120% YoY (51% ex-45x), leverage 0.89x; CEO transition to Richard Stewart; Kloof gold ops weak; Keliber build on track but start-up under review; 45x credits ZAR 5.2bn; palladium remedy filed; 3 fatalities.
- **2024 Q2:** Sibanye Stillwater strengthened its balance sheet by >ZAR25bn, pursued US PGM restructuring, secured Keliber financing and maintained guidance despite commodity volatility.
- **2023 Q4:** Sibanye Stillwater prioritizes balance sheet protection amid PGM price decline, restructuring US ops, advancing Keliber lithium, and targeting gold cost cuts while maintaining constructive PGM outlook.
- **2023 Q2:** Sibanye‑Stillwater reports a mixed H1 2023 with gold recovery offsetting weaker PGM margins, highlights cost control, renewable energy progress and ongoing skill‑shortage and legal challenges.
- **2022 Q4:** Sibanye-Stillwater reports strong safety improvements, robust balance sheet with net cash position, declares industry-leading 6% dividend yield, advances Keliber lithium project and US PGM repositioning, but flags up to 15% production loss risk from South African load shedding.
- **2022 Q2:** Sibanye Stillwater highlighted safety improvements and strategic positioning while grappling with industrial action, flood disruptions and illegal‑mining risks, yet kept costs modest and maintained guidance.
- **2021 Q3:** —

## Theme arcs

- **Safety improvements** (improving): First highlighted in 2022‑Q2 and reinforced in 2022‑Q4
- **Balance‑sheet strength** (improving): Robust cash position in 2022‑Q4, ZAR 25 bn boost in 2024‑Q2, EBITDA +120% in 2025‑Q2
- **PGM demand outlook** (stable): Supply constraints noted 2022‑Q4, anchored demand through 2025
- **Lithium demand** (deteriorating): Strong deficit noted 2022‑Q4, market pressure mentioned 2024‑Q2 and 2025‑Q2
- **Cost control and margins** (improving): From modest cost rise in 2022‑Q2 to $1,000/oz target and cost reductions in 2025
- **Operational risk (load‑shedding, seismicity)** (stable): Risk flagged from 2022‑Q4 onward and persists through 2025
- **US PGM restructuring** (improving): Restructuring announced 2023‑Q4, at‑risk in 2024‑Q2, cost benefits evident 2025‑Q2
- **Renewable‑energy progress** (improving): Castle Wind Farm delivered 2023‑Q2, PPAs on‑track 2024‑Q2
- **Skill shortages** (stable): US labour gaps noted 2023‑Q2 and reiterated 2024‑Q2
- **Legal and regulatory challenges** (new): Appian litigation 2023‑Q2, financing‑terms risk 2024‑Q2

## Guidance path

2021 Q3:vague → 2022 Q2:maintained → 2022 Q4:maintained → 2023 Q2:maintained → 2023 Q4:vague → 2024 Q2:maintained → 2025 Q2:vague → 2025 Q4:vague

---

Research context only. Not personalized investment advice.

API: `GET /bff/api/bigfive/earnings-intel/SBSW`